Mark Austin
Director of Finance/CFO presso PERSPECTIVE THERAPEUTICS, INC.
Patrimonio netto: 99 996 $ in data 31/03/2024
Profilo
Mark J.
Austin is currently working as the Co-CFO, Secretary, CAO, VP & Controller at Perspective Therapeutics, Inc. He previously worked as the Chief Financial & Accounting Officer at IsoRay, Inc. from 2017 to 2018.
Prior to that, he held the position of Manager & Senior Associate at KPMG Advisory Sp zoo Spolka Komandytowa from 2009 to 2017.
Mr. Austin completed his undergraduate degree at Santa Clara University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
23/04/2024 | 84 030 ( 0.01% ) | 99 996 $ | 31/03/2024 |
Posizioni attive di Mark Austin
Società | Posizione | Inizio |
---|---|---|
PERSPECTIVE THERAPEUTICS, INC. | Director of Finance/CFO | 01/07/2017 |
Precedenti posizioni note di Mark Austin
Società | Posizione | Fine |
---|---|---|
KPMG Advisory SP ZOO Spolka Komandytowa
KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The private company is based in Warsaw, Poland. | Corporate Officer/Principal | 01/07/2017 |
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Director of Finance/CFO | - |
Formazione di Mark Austin
Santa Clara University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
IsoRay, Inc.
IsoRay, Inc. Medical SpecialtiesHealth Technology IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The firm focuses on the treatment of cancer and other malignant diseases. Its core product is Cesium-131, a radioisotope for the treatment of malignant tumors. The company was founded by Lance A. Bray in 1983 and is headquartered in Richland, WA. | Health Technology |
KPMG Advisory SP ZOO Spolka Komandytowa
KPMG Advisory SP ZOO Spolka Komandytowa Investment ManagersFinance Part of KPMG CEE Holdings Ltd., KPMG Advisory Sp zoo Spolka Komandytowa provides financial advisory services. The private company is based in Warsaw, Poland. | Finance |
Perspective Therapeutics, Inc. |
- Borsa valori
- Insiders
- Mark Austin